Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia Vitali

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 28, 2020
Controversial Role of Lecithin:Cholesterol Acyltransferase in the Development of Atherosclerosis: New Insights From an LCAT ActivatorCecilia Vitali, Marina Cuchel
Arteriosclerosis, Thrombosis, and Vascular Biology|June 26, 2015
ABCA1 and Inflammation: From Animal Models to HumansXin Bi, Cecilia Vitali, Marina Cuchel
Cardiovascular Research|June 9, 2014
HDL and cholesterol handling in the brainCecilia Vitali, Cheryl L Wellington, Laura Calabresi
Current Opinion in Lipidology|December 6, 2022
Novel therapeutic opportunities for familial lecithin:cholesterol acyltransferase deficiency: promises and challengesCecilia Vitali, Daniel J Rader, Marina Cuchel
Circulation|October 26, 2018
Is Low-Density Lipoprotein Cholesterol the Key to Interpret the Role of Lecithin:Cholesterol Acyltransferase in Atherosclerosis?Cecilia Vitali, Alan T Remaley, Marina Cuchel
Circulation|September 6, 2022
Gain-of-Function Variants in Lipid Genes Enhance Biological Insight and Point Toward Therapeutic OpportunitiesSylvia Stankov, Cecilia Vitali, Daniel J Rader
Current Cardiology Reports|November 6, 2017
HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human GeneticsCecilia Vitali, Sumeet A Khetarpal, Daniel J Rader
Journal of Atherosclerosis and Thrombosis|November 27, 2015
Role of LCAT in AtherosclerosisAlice Ossoli, Sara Simonelli, Cecilia Vitali, et al.
Journal of Clinical Lipidology|June 23, 2024
Longitudinal analysis of clinical and laboratory biomarkers in a patient with familial lecithin: cholesterol acyltransferase deficiency (FLD) and accelerated eGFR decline: A case studyGregory Alfaro, Jay Pendyala, Michael Sulewski, et al.
Journal of Lipid Research|March 14, 2026
Post-heparin plasma lipase activities in patients with severe hypertriglyceridemia treated with evinacumabCecilia Vitali, Poulabi Banerjee, Robert Pordy, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Arteriosclerosis, Thrombosis, and Vascular Biology|December 28, 2020
Controversial Role of Lecithin:Cholesterol Acyltransferase in the Development of Atherosclerosis: New Insights From an LCAT ActivatorCecilia Vitali, Marina Cuchel
Arteriosclerosis, Thrombosis, and Vascular Biology|June 26, 2015
ABCA1 and Inflammation: From Animal Models to HumansXin Bi, Cecilia Vitali, Marina Cuchel
Cardiovascular Research|June 9, 2014
HDL and cholesterol handling in the brainCecilia Vitali, Cheryl L Wellington, Laura Calabresi
Current Opinion in Lipidology|December 6, 2022
Novel therapeutic opportunities for familial lecithin:cholesterol acyltransferase deficiency: promises and challengesCecilia Vitali, Daniel J Rader, Marina Cuchel
Circulation|October 26, 2018
Is Low-Density Lipoprotein Cholesterol the Key to Interpret the Role of Lecithin:Cholesterol Acyltransferase in Atherosclerosis?Cecilia Vitali, Alan T Remaley, Marina Cuchel
Circulation|September 6, 2022
Gain-of-Function Variants in Lipid Genes Enhance Biological Insight and Point Toward Therapeutic OpportunitiesSylvia Stankov, Cecilia Vitali, Daniel J Rader
Current Cardiology Reports|November 6, 2017
HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human GeneticsCecilia Vitali, Sumeet A Khetarpal, Daniel J Rader
Journal of Atherosclerosis and Thrombosis|November 27, 2015
Role of LCAT in AtherosclerosisAlice Ossoli, Sara Simonelli, Cecilia Vitali, et al.
Journal of Clinical Lipidology|June 23, 2024
Longitudinal analysis of clinical and laboratory biomarkers in a patient with familial lecithin: cholesterol acyltransferase deficiency (FLD) and accelerated eGFR decline: A case studyGregory Alfaro, Jay Pendyala, Michael Sulewski, et al.
Journal of Lipid Research|March 14, 2026
Post-heparin plasma lipase activities in patients with severe hypertriglyceridemia treated with evinacumabCecilia Vitali, Poulabi Banerjee, Robert Pordy, et al.
Pageof 4